Aqua Medical Highlights 100% Insulin Elimination for 12 Months in Patients with Type 2 Diabetes with its Breakthrough “Through-the-Scope” Procedure at Digestive Disease Week® (DDW) 2026
PLEASANTON, Calif., May 5, 2026 /PRNewswire/ — Aqua Medical, Inc., a pioneer in Endoscopic Metabolic Restoration (www.aquaendoscopy.com), yesterday announced the presentation of 12-month follow-up outside US clinical data for its proprietary radiofrequency vapor ablation (RFVA) platform at Digestive Disease Week® (DDW) 2026, highlighting the potential of its Proximal Intestinal Mucosal Ablation (PIMA) procedure to deliver durable, procedure-based treatment for type 2 diabetes. Data presented at DDW […]